NEW YORK, Aug. 26 (GenomeWeb News) - Invitrogen and the Scripps Research Institute are collaborating on new methods to study membrane proteins, the two partners said yesterday.
Under the direction of Geoffrey Chang, a group leader at Scripps, scientists at Scripps and Invitrogen's proteomics R&D group will try to develop better ways to express, isolate, and characterize membrane proteins.
Invitrogen will have the right to commercialize resulting technologies in the research and drug-screening markets.